Traders Buy High Volume of Call Options on Tempus AI (NASDAQ:TEM)

Tempus AI, Inc. (NASDAQ:TEM) was the recipient of unusually large options trading on Tuesday. Investors acquired 43,297 call options on the company. This is an increase of approximately 601% compared to the average volume of 6,178 call options.

Insider Buying and Selling

In other news, major shareholder Bradley A. Keywell sold 395,800 shares of the company’s stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total value of $16,999,610.00. Following the sale, the insider now directly owns 16,164,449 shares in the company, valued at $694,263,084.55. This represents a 2.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Eric P. Lefkofsky sold 187,655 shares of the firm’s stock in a transaction that occurred on Wednesday, December 18th. The stock was sold at an average price of $37.54, for a total transaction of $7,044,568.70. Following the sale, the chief executive officer now owns 9,557,283 shares in the company, valued at approximately $358,780,403.82. This trade represents a 1.93 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,300,761 shares of company stock valued at $51,271,197 over the last quarter.

Institutional Investors Weigh In On Tempus AI

Institutional investors have recently modified their holdings of the business. NEA Management Company LLC boosted its holdings in shares of Tempus AI by 17.8% during the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock valued at $304,846,000 after acquiring an additional 813,169 shares during the period. Novo Holdings A S bought a new stake in Tempus AI in the 2nd quarter valued at about $142,605,000. ARK Investment Management LLC boosted its stake in Tempus AI by 355.0% during the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock valued at $134,604,000 after purchasing an additional 1,855,459 shares during the period. Sumitomo Mitsui Trust Group Inc. grew its position in Tempus AI by 1,591.2% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock worth $68,922,000 after purchasing an additional 1,145,698 shares during the last quarter. Finally, Franklin Resources Inc. increased its stake in shares of Tempus AI by 1.0% in the third quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock valued at $45,920,000 after purchasing an additional 8,387 shares during the period. Institutional investors own 24.22% of the company’s stock.

Tempus AI Stock Up 39.3 %

TEM traded up $13.82 during trading hours on Tuesday, hitting $48.97. 19,011,556 shares of the stock were exchanged, compared to its average volume of 4,943,078. The stock has a 50-day simple moving average of $45.18 and a 200-day simple moving average of $47.27. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI has a 12 month low of $22.89 and a 12 month high of $79.49.

Wall Street Analysts Forecast Growth

TEM has been the subject of several research analyst reports. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and upped their price target for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. Piper Sandler reissued a “neutral” rating and set a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Guggenheim assumed coverage on shares of Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price target on the stock. Wolfe Research initiated coverage on shares of Tempus AI in a research note on Friday, December 13th. They issued an “outperform” rating and a $60.00 target price on the stock. Finally, Loop Capital decreased their price target on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, January 14th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $56.36.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.